BioWorld reported on July 27, 2001 that NewBiotics raised $11 million in a Series C round. The reported purpose of the financing was to support the company's programs. The short item did not provide details on the company's specific product candidates or technological focus. No operating metrics such as revenue or user counts were disclosed in the article. Investor names, terms of the round, and instruments beyond the Series C designation were not provided. The BioWorld piece is a brief financing announcement limited to the $11 million Series C and its stated purpose.

Total raised

$11M

Funding rounds

1

Latest round

Series C

Latest activity

Oct 2024